Skip to main content

Abstract

Acute liver failure (ALF) and acute-on-chronic liver failure (ACLF) in children are rare but catastrophic clinical conditions with a high mortality and morbidity. Massive hepatocyte necrosis leads to profound impairment in synthetic, excretory, and detoxifying ability of the liver and leads to coagulopathy, jaundice, and encephalopathy. Circulating inflammatory mediators and toxins lead to multi-organ failure and death. As there are yet no treatment options for reversing or halting hepatocellular necrosis, current therapies focus more on supporting the failing organs, while the liver either spontaneously regenerates or child undergoes a liver transplant. Continuous renal replacement therapy (CRRT) forms one of such essential pillars of support implemented to successfully manage a critically ill child with ALF or ACLF. CRRT is either used alone or in combination of other blood purification modalities to attenuate the deleterious effects of a failing liver in the host. This chapter discusses the pathophysiology of liver failure, indications, benefits, and challenges of CRRT in pediatric liver failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arroyo V, Jalan R. Acute-on-chronic liver failure: definition, diagnosis, and clinical characteristics. Semin Liver Dis. 2016;36(2):109–16.

    Article  Google Scholar 

  2. Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13(3):131–49.

    Article  CAS  Google Scholar 

  3. Squires RH. End-stage liver disease in children. Curr Treat Options Gastroenterol. 2001;4(5):409–21.

    Article  Google Scholar 

  4. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8.

    Article  Google Scholar 

  5. Miloh T, Desai MS. Chapter 419: acute liver failure. In: Rudolph’s pediatrics. 23rd ed. New York: McGraw Hill; 2018.

    Google Scholar 

  6. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369(26):2525–34.

    Article  CAS  Google Scholar 

  7. Bacchetta J, Mekahli D, Rivet C, Demede D, Leclerc AL. Pediatric combined liver-kidney transplantation: a 2015 update. Curr Opin Organ Transplant. 2015;20(5):543–9.

    Article  CAS  Google Scholar 

  8. Cheng XS, Tan JC, Kim WR. Management of renal failure in end-stage liver disease: a critical appraisal. Liver Transpl. 2016;22(12):1710–9.

    Article  Google Scholar 

  9. Maiwall R, Sarin SK, Moreau R. Acute kidney injury in acute on chronic liver failure. Hepatol Int. 2016;10(2):245–57.

    Article  Google Scholar 

  10. Wong F. Acute kidney injury in liver cirrhosis: new definition and application. Clin Mol Hepatol. 2016;22(4):415–22.

    Article  Google Scholar 

  11. Bucsics T, Krones E. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterol Rep (Oxf). 2017;5(2):127–37.

    Article  Google Scholar 

  12. Davenport A. Continuous renal replacement therapy for liver disease. Hemodial Int. 2003;7(4):348–52.

    Article  Google Scholar 

  13. Deep A, Saxena R, Jose B. Acute kidney injury in children with chronic liver disease. Pediatr Nephrol. 2018. https://doi.org/10.1007/s00467-018-3893-7.

    Article  Google Scholar 

  14. Krag A, Bendtsen F, Henriksen JH, Moller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59(1):105–10.

    Article  CAS  Google Scholar 

  15. Krag A, Bendtsen F, Burroughs AK, Moller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses. 2012;79(1):53–5.

    Article  Google Scholar 

  16. Durand F, Graupera I, Gines P, Olson JC, Nadim MK. Pathogenesis of hepatorenal syndrome: implications for therapy. Am J Kidney Dis. 2016;67(2):318–28.

    Article  CAS  Google Scholar 

  17. Francoz C, Nadim MK, Durand F. Kidney biomarkers in cirrhosis. J Hepatol. 2016;65(4):809–24.

    Article  CAS  Google Scholar 

  18. Schaefer B, Ujszaszi A, Schaefer S, Heckert KH, Schaefer F, Schmitt CP. Safety and efficacy of tandem hemodialysis and plasma exchange in children. Clin J Am Soc Nephrol. 2014;9(9):1563–70.

    Article  CAS  Google Scholar 

  19. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg. 2001;234(3):418–24.

    Article  CAS  Google Scholar 

  20. Deep A, Stewart CE, Dhawan A, Douiri A. Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med. 2016;44(10):1910–9.

    Article  CAS  Google Scholar 

  21. Durand F, Olson JC, Nadim MK. Renal dysfunction and cirrhosis. Curr Opin Crit Care. 2017;23(6):457–62.

    Article  Google Scholar 

  22. Karvellas CJ, Durand F, Nadim MK. Acute kidney injury in cirrhosis. Crit Care Clin. 2015;31(4):737–50.

    Article  Google Scholar 

  23. Hadjihambi A, Arias N, Sheikh M, Jalan R. Hepatic encephalopathy: a critical current review. Hepatol Int. 2018;12(Suppl 1):135–47.

    Article  Google Scholar 

  24. Romero-Gomez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. J Hepatol. 2015;62(2):437–47.

    Article  CAS  Google Scholar 

  25. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41(5):1179–97.

    Article  Google Scholar 

  26. Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2017;67(2):711–20.

    Article  Google Scholar 

  27. Chevret L, Durand P, Lambert J, Essouri S, Balu L, Devictor D, et al. High-volume hemofiltration in children with acute liver failure*. Pediatr Crit Care Med. 2014;15(7):e300–5.

    Article  Google Scholar 

  28. Kim JM, Jo YY, Na SW, Kim SI, Choi YS, Kim NO, et al. The predictors for continuous renal replacement therapy in liver transplant recipients. Transplant Proc. 2014;46(1):184–91.

    Article  CAS  Google Scholar 

  29. Alam S, Lal BB. Metabolic liver diseases presenting as acute liver failure in children. Indian Pediatr. 2016;53(8):695–701.

    Article  Google Scholar 

  30. Gupta S, Fenves AZ, Hootkins R. The role of RRT in hyperammonemic patients. Clin J Am Soc Nephrol. 2016;11(10):1872–8.

    Article  CAS  Google Scholar 

  31. Banares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57(3):1153–62.

    Article  CAS  Google Scholar 

  32. Saliba F, Samuel D. Artificial liver support: a real step forward. Minerva Med. 2015;106(1):35–43.

    CAS  PubMed  Google Scholar 

  33. Saliba F, Camus C, Durand F, Mathurin P, Letierce A, Delafosse B, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med. 2013;159(8):522–31.

    Article  Google Scholar 

  34. Saliba F. The molecular adsorbent recirculating system (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care. 2006;10(1):118.

    Article  Google Scholar 

  35. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, et al. Comparison of molecular adsorbents recirculating system (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant. 2011;26(11):3633–9.

    Article  CAS  Google Scholar 

  36. Schaefer B, Schmitt CP. The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol. 2013;28(9):1763–9.

    Article  Google Scholar 

  37. Lexmond WS, Van Dael CM, Scheenstra R, Goorhuis JF, Sieders E, Verkade HJ, et al. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation. Liver Transpl. 2015;21(3):369–80.

    Article  Google Scholar 

  38. Akcan AA, Srivaths P, Himes RW, Tufan PN, Lam F, Nguyen T, et al. Hybrid extracorporeal therapies as a bridge to pediatric liver transplantation. Pediatr Crit Care Med. 2018;19(7):e342–9.

    Google Scholar 

  39. Habib M, Roberts LN, Patel RK, Wendon J, Bernal W, Arya R. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation. Liver Int. 2014;34(5):672–8.

    Article  CAS  Google Scholar 

  40. Goonasekera CD, Wang J, Bunchman TE, Deep A. Factors affecting circuit life during continuous renal replacement therapy in children with liver failure. Ther Apher Dial. 2015;19(1):16–22.

    Article  Google Scholar 

  41. Chadha V, Garg U, Warady BA, Alon US. Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol. 2002;17(10):819–24.

    Article  Google Scholar 

  42. Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M. Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol. 2004;19(2):208–12.

    Article  Google Scholar 

  43. Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant. 2005;20(7):1416–21.

    Article  Google Scholar 

  44. Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, et al. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One. 2017;12(8):e0182134.

    Article  Google Scholar 

  45. Santiago MJ, Lopez-Herce J, Urbano J, Solana MJ, Del CJ, Ballestero Y, et al. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Crit Care. 2009;13(6):R184.

    Article  Google Scholar 

  46. Thorat A, Jeng LB. Management of renal dysfunction in patients with liver cirrhosis: role of pretransplantation hemodialysis and outcomes after liver transplantation. Semin Vasc Surg. 2016;29(4):227–35.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ayse Akcan-Arikan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Desai, M., Akcan-Arikan, A. (2019). Advances in Liver Failure and Management. In: Sethi, S., Raina, R., McCulloch, M., Bunchman, T. (eds) Critical Care Pediatric Nephrology and Dialysis: A Practical Handbook. Springer, Singapore. https://doi.org/10.1007/978-981-13-2276-1_23

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2276-1_23

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2275-4

  • Online ISBN: 978-981-13-2276-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics